Verrica Pharmaceuticals Inc (VRCA) USD0.0001

Sell:$7.00Buy:$8.11$0.36 (4.55%)

Prices delayed by at least 15 minutes
Sell:$7.00
Buy:$8.11
Change:$0.36 (4.55%)
Prices delayed by at least 15 minutes
Sell:$7.00
Buy:$8.11
Change:$0.36 (4.55%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
25 November 2025
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
1,375,380$4.24$5,835,049.653,958,189
25 November 2025
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
2,750,762$4.24$11,670,107.793,348,372
25 November 2025
Jayson RiegerPresident/CEO
Buy
Regular purchase transaction
94,311$4.24$400,114.42182,593
25 November 2025
David ZawitzCOO
Buy
Regular purchase transaction
10,000$4.24$42,425.0021,000
25 November 2025
John J KirbyCFO
Buy
Regular purchase transaction
3,536$4.24$15,001.488,962
25 November 2025
Noah L RosenbergOther Level A
Buy
Regular purchase transaction
2,357$4.24$9,999.572,357
17 March 2025
Christopher G HayesChief Legal/Compliance Officer
Sell
Tax related
4,315$0.65$2,804.75176,458

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
25 November 2025
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
2,750,762$4.24$11,670,107.793,348,372
25 November 2025
Paul B. ManningChairman of the Board
Buy
Regular purchase transaction
1,375,380$4.24$5,835,049.653,958,189
25 November 2025
Jayson RiegerPresident/CEO
Buy
Regular purchase transaction
94,311$4.24$400,114.42182,593
25 November 2025
David ZawitzCOO
Buy
Regular purchase transaction
10,000$4.24$42,425.0021,000
25 November 2025
John J KirbyCFO
Buy
Regular purchase transaction
3,536$4.24$15,001.488,962

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.